Frequency, Features, and Recommendations for Preventing Adverse Events in Supervised Exercise Programs for Pediatric Oncology Patients - Top-Institutions - MDSpire

Frequency, Features, and Recommendations for Preventing Adverse Events in Supervised Exercise Programs for Pediatric Oncology Patients

  • By

  • Gauß, Gabriele

  • Rueegg, Corina Silvia

  • Schindera, Christina

  • Meisegeier, Stefan

  • Stalf, Hannah

  • Sundermeier, Thorben

  • Maiwald, Michael

  • Dietrich, Melisa

  • Reus, Annika

  • Tomaskovic, Aleksandar

  • Götte, Miriam

  • March 31, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    St. Jude Children's Research Hospital
    St. Jude Children's Research Hospital

    Memphis, TN

    Key Differentiators

    • Pediatric Oncology
    • Rehabilitation Medicine
    • Exercise Oncology

  • #2

    Dana-Farber/Boston Children's Cancer and Blood Disorders Center
    Dana-Farber/Boston Children's Cancer and Blood Disorders Center

    Boston, MA

    Key Differentiators

    • Pediatric Oncology
    • Exercise Physiology
    • Rehabilitation

  • #3

    Children's Hospital of Philadelphia (CHOP)
    Children's Hospital of Philadelphia (CHOP)

    Philadelphia, PA

    Key Differentiators

    • Pediatric Oncology
    • Physical Medicine and Rehabilitation
    • Exercise Science

  • #4

    Seattle Children's Hospital
    Seattle Children's Hospital

    Seattle, WA

    Key Differentiators

    • Pediatric Oncology
    • Rehabilitation Medicine
    • Exercise Oncology

  • #5

    Children's National Hospital
    Children's National Hospital

    Washington, DC

    Key Differentiators

    • Pediatric Oncology
    • Physical Therapy
    • Exercise Science

Original Source(s)

Frequency, Features, and Recommendations for Preventing Adverse Events in Supervised Exercise Programs for Pediatric Oncology Patients

  • by Gauß, Gabriele , Rueegg, Corina Silvia, Schindera, Christina , Meisegeier, Stefan , Stalf, Hannah , Sundermeier, Thorben , Maiwald, Michael , Dietrich, Melisa , Reus, Annika , Tomaskovic, Aleksandar , Götte, Miriam

  • March 31, 2026

Related Content

Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry

Case Report: [225Ac]Ac-PSMA-617 therapy in a patient with metastatic castration-resistant prostate cancer (mCRPC) and intracranial meningioma

Use of PCSK9 Inhibitors Among Patients Receiving Immune Checkpoint Inhibitors for Cancer